Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 11, 2022 03:07 ET | Source: Growth Plus Reports

Influenza Medication Market Size (2022-2030) - Sanofi S.A., Lupin Limited, Novartis AG, Vitaris AG and AstraZaneca Plc

Pune, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Influenza Medication Market is expected to clock US$ 1510 million by 2030 and to...
May 03, 2021 08:52 ET | Source: Fortune Business Insights

Influenza Medication Market Forecast [2019-2026] | Size Is Projected to Reach USD 993.7 Million by 2026, Exhibiting a CAGR of 2.2%

Pune, India, May 03, 2021 (GLOBE NEWSWIRE) -- The global “influenza medication market” size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period....
October 27, 2020 08:20 ET | Source: Fortune Business Insights

Influenza Medication Market to Hit $993.7 Million with 2.2% CAGR by 2026; Large Unmet Needs of Patient Population to Boost Market Growth in Latin America: Fortune Business Insights™

Pune, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The global influenza medication market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing...
February 06, 2020 02:44 ET | Source: Fortune Business Insights

Influenza Medication Market to Reach $993.7 Million by 2026; Growing Research into the Changing Nature of the Influenza Virus to Fuel the Market: Fortune Business Insights™

Pune, Feb. 06, 2020 (GLOBE NEWSWIRE) -- The global Influenza Medication Market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing...